These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 8662918)

  • 1. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
    Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC
    J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
    FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gp130 in human myeloma/plasmacytoma.
    Tani Y; Nishimoto N; Ogata A; Shima Y; Yoshizaki K; Kishimoto T
    Curr Top Microbiol Immunol; 1995; 194():229-33. PubMed ID: 7895494
    [No Abstract]   [Full Text] [Related]  

  • 5. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1.
    Benigni F; Fantuzzi G; Sacco S; Sironi M; Pozzi P; Dinarello CA; Sipe JD; Poli V; Cappelletti M; Paonessa G; Pennica D; Panayotatos N; Ghezzi P
    Blood; 1996 Mar; 87(5):1851-4. PubMed ID: 8634432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
    Vernallis AB; Hudson KR; Heath JK
    J Biol Chem; 1997 Oct; 272(43):26947-52. PubMed ID: 9341130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
    Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
    J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.
    Watanabe D; Yoshimura R; Khalil M; Yoshida K; Kishimoto T; Taga T; Kiyama H
    Eur J Neurosci; 1996 Aug; 8(8):1630-40. PubMed ID: 8921254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A ciliary neurotrophic factor-sensitive human myeloma cell line.
    Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
    Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
    Stahl N; Boulton TG; Farruggella T; Ip NY; Davis S; Witthuhn BA; Quelle FW; Silvennoinen O; Barbieri G; Pellegrini S
    Science; 1994 Jan; 263(5143):92-5. PubMed ID: 8272873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional requirement of gp130-mediated signaling for growth and survival of mouse primordial germ cells in vitro and derivation of embryonic germ (EG) cells.
    Koshimizu U; Taga T; Watanabe M; Saito M; Shirayoshi Y; Kishimoto T; Nakatsuji N
    Development; 1996 Apr; 122(4):1235-42. PubMed ID: 8620850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130.
    Taga T; Narazaki M; Yasukawa K; Saito T; Miki D; Hamaguchi M; Davis S; Shoyab M; Yancopoulos GD; Kishimoto T
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10998-1001. PubMed ID: 1438305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
    Gyotoku E; Morita E; Kameyoshi Y; Hiragun T; Yamamoto S; Hide M
    Arch Dermatol Res; 2001 Nov; 293(10):508-14. PubMed ID: 11820727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of receptor binding sites on human interleukin-11 by molecular modeling-guided mutagenesis.
    Tacken I; Dahmen H; Boisteau O; Minvielle S; Jacques Y; Grötzinger J; Küster A; Horsten U; Blanc C; Montero-Julian FA; Heinrich PC; Müller-Newen G
    Eur J Biochem; 1999 Oct; 265(2):645-55. PubMed ID: 10504396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonistic and antagonistic variants of ciliary neurotrophic factor (CNTF) reveal functional differences between membrane-bound and soluble CNTF alpha-receptor.
    Di Marco A; Gloaguen I; Demartis A; Saggio I; Graziani R; Paonessa G; Laufer R
    J Biol Chem; 1997 Sep; 272(37):23069-75. PubMed ID: 9287306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
    J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.